{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:48:49Z","timestamp":1759942129082},"reference-count":42,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.thromres.2013.11.029","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T16:45:39Z","timestamp":1386348339000},"page":"257-264","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy"],"prefix":"10.1016","volume":"133","author":[{"given":"Sarolta","family":"Le\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Vargov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Hizoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs\u00f3fia","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Gul\u00e1csi-B\u00e1rdos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs\u00f3fia","family":"Sztupinszki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Apr\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Pr\u00e9da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emese","family":"T\u00f3th-Zs\u00e1mboki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00f3bert G.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.11.029_bb0005","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ahj.2005.01.044","article-title":"Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: Further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study","volume":"150","author":"Lewis","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2013.11.029_bb0010","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2013.11.029_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ahj.2004.03.028","article-title":"Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial","volume":"148","author":"Bhatt","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2013.11.029_bb0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ccd.10497","article-title":"Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation","volume":"59","author":"Barragan","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.thromres.2013.11.029_bb0025","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.11.029_bb0030","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.029_bb0035","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","article-title":"Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.029_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH09-05-0284","article-title":"Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting","volume":"103","author":"Sibbing","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.029_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"Sibbing","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.029_bb0050","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1160\/TH07-04-0296","article-title":"ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome","volume":"98","author":"Frere","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.029_bb0055","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2013.11.029_bb0060","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2013.11.029_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcin.2011.12.009","article-title":"Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction","volume":"5","author":"Ahn","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.thromres.2013.11.029_bb0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2013.11.029_bb0075","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","article-title":"Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"122","author":"James","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.11.029_bb0080","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2013.11.029_bb0085","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehr236","volume":"32","author":"Hamm","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2013.11.029_bb0090","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2013.11.029_bb0095","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2013.11.029_bb0100","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2012.02.026","volume":"59","author":"Trenk","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.029_bb0105","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2013.11.029_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jama.2012.17312","article-title":"Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization: The TRILOGY ACS Platelet Function Substudy","volume":"308","author":"Gurbel","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2013.11.029_bb0115","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1160\/TH08-03-0158","article-title":"Analysis of platelet alpha 2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy","volume":"100","author":"Beres","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.029_bb0120","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1538-7836.2009.03458.x","article-title":"Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH","volume":"7","author":"Cattaneo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.029_bb0125","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","article-title":"Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data","volume":"58","author":"Brar","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.029_bb0130","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.029_bb0135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/09537100802351065","article-title":"Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target","volume":"19","author":"Gurbel","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2013.11.029_bb0140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.thromres.2011.03.018","article-title":"Evidence of increased platelet reactivity in the first six months after acute ST segment elevation myocardial infarction","volume":"128","author":"Scalone","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.11.029_bb0145","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1055\/s-0037-1615952","article-title":"Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction","volume":"85","author":"Mathur","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.029_bb0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/01.CIR.93.2.229","article-title":"Platelet function in acute myocardial infarction treated with direct angioplasty","volume":"93","author":"Gawaz","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2013.11.029_bb0155","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.thromres.2010.01.003","article-title":"Sustained enhancement of residual platelet reactivity after coronary stenting in patients with myocardial infarction compared to elective patients","volume":"125","author":"Althoff","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.11.029_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.thromres.2006.08.012","article-title":"Clopidogrel resistance?","volume":"120","author":"Gurbel","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.11.029_bb0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ahj.2008.11.019","article-title":"Facts and controversies of aspirin and clopidogrel therapy","volume":"157","author":"Faxon","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2013.11.029_bb0170","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jacc.2005.01.034","article-title":"Resistance to clopidogrel: a review of the evidence","volume":"45","author":"Nguyen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.thromres.2013.11.029_bb0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/eurheartj\/ehi684","article-title":"Aspirin and clopidogrel resistance: an emerging clinical entity","volume":"27","author":"Wang","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.thromres.2013.11.029_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09537100903391015","article-title":"Low platelet disaggregation predicts poor response to 150mg clopidogrel in patients with elevated platelet reactivity","volume":"21","author":"Aradi","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2013.11.029_bb0185","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/2012.jama.10779","article-title":"Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes","volume":"308","author":"Andersson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2013.11.029_bb0190","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2013.11.029_bb0200","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0091270009343005","article-title":"Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans","volume":"50","author":"Farid","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.thromres.2013.11.029_bb0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1160\/TH12-08-0552","article-title":"Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting","volume":"109","author":"Bernlochner","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.029_bb0210","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1160\/TH11-09-0622","article-title":"Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel","volume":"107","author":"Aradi","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.11.029_bb0215","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.106.666826","article-title":"Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents","volume":"115","author":"Serruys","year":"2007","journal-title":"Circulation"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813005653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813005653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T16:09:26Z","timestamp":1564934966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813005653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0049384813005653"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.11.029","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}